type in your search and press enter
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
You May Also Like
PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF IV IRON DOSING STRATEGY
PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS IRON DOSING STRATEGY ALLOWING HIGHER ...
numares initiates pan-European multicenter study of AXINON® renalTX-SCORE® on kidney allograft rejection
PARASOL multicenter study to continue building clinical case for non-invasive renal allograft rejection testing ...
